Arno Therapeutics, Inc
company.status.inactiveCIK 1195116fmd_0D433RFGX7H4HNZAA9HVZXHYMAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2016, 30 periods
Latest annual · FY2015
Millions- Operating income
- (13)
- Net income
- (12)
- Free cash flow
- (10)
Latest quarter · Q3 FY2016
Millions- Operating income
- (2)
- Net income
- (4)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2010 to FY2015
- n/m
Arno Therapeutics, Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$13.4 million | -$21.5 million | 10-K 2016-03-30 · proof | |
| Net income | -$11.5 million | $7.8 million | -248.1% | 10-K 2016-03-30 · proof |
| Cash from operating activities | -$10 million | -$18.8 million | 10-K 2016-03-30 · proof | |
| Free cash flow | -$10 million | -$18.8 million | 10-K 2016-03-30 · proof | |
| Total assets | $361,240 | $8.2 million | -95.6% | 10-K 2016-03-30 · proof |
| Total liabilities | $9 million | $8.8 million | +1.7% | 10-K 2016-03-30 · proof |
| Cash and cash equivalents | $66,988 | $7.9 million | -99.2% | 10-K 2016-03-30 · proof |
- What was Arno Therapeutics, Inc's operating income in fiscal 2015?
- Arno Therapeutics, Inc reported operating income of -$13.4 million for fiscal 2015 (the year ended Dec 31, 2015), against -$21.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was Arno Therapeutics, Inc's net income in fiscal 2015?
- Arno Therapeutics, Inc reported net income of -$11.5 million for fiscal 2015 (the year ended Dec 31, 2015), against $7.8 million the year before (-248.1%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was Arno Therapeutics, Inc's cash from operating activities in fiscal 2015?
- Arno Therapeutics, Inc reported cash from operating activities of -$10 million for fiscal 2015 (the year ended Dec 31, 2015), against -$18.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was Arno Therapeutics, Inc's free cash flow in fiscal 2015?
- Arno Therapeutics, Inc reported free cash flow of -$10 million for fiscal 2015 (the year ended Dec 31, 2015), against -$18.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are Arno Therapeutics, Inc's total assets?
- As of Dec 31, 2015, Arno Therapeutics, Inc reported total assets of $361,240, against $8.2 million a year earlier (-95.6%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are Arno Therapeutics, Inc's total liabilities?
- As of Dec 31, 2015, Arno Therapeutics, Inc reported total liabilities of $9 million, against $8.8 million a year earlier (+1.7%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are Arno Therapeutics, Inc's cash and cash equivalents?
- As of Dec 31, 2015, Arno Therapeutics, Inc reported cash and cash equivalents of $66,988, against $7.9 million a year earlier (-99.2%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1195116&period_type=annual&limit=5"Information only, not investment advice.